Data / Form D filings / ONCOQUEST PHARMA USA, INC
ONCOQUEST PHARMA USA, INC: Form D filings
ONCOQUEST PHARMA USA, INC, a pharmaceuticals company in Miryang Si, Gyeongsangnamdo, Korea, Republic Of, filed 2 Form D notices with the SEC in 2021. The latest, on May 11, 2021, reports $360,000 sold of a $360,000 offering to 1 investor.
Find out what ONCOQUEST PHARMA USA, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 670-21, SANNAE-RO, SANNAE-MYEON, Miryang Si, Gyeongsangnamdo, Korea, Republic Of, 50414
- Phone
- 82-55-352-4860
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1839861
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2021 | New notice | $360,000 | $360,000 | $0 | 1 | Apr 27, 2021 | sec.gov |
| Jan 13, 2021 | New notice | $510,000 | $510,000 | $0 | 1 | Dec 10, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ragupathy Madiyalakan | Executive Officer, Director | |
| Alex Jung | Executive Officer, Director | |
| Lyn Lim | Director | |
| Karthik Radhakrishnan | Executive Officer, Director |
Every Form D from the week of May 10, 2021 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ONCOQUEST PHARMA USA, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.